Crossmark

Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma

Published Online: 2020-12-01

Published Print: 2020-12

Authors

Akhtar, Javed

Priya, Ratna

Jain, Vaishali

Sakhuja, Puja

Agarwal, Anil Kumar

Goyal, Surbhi

Polisetty, Ravindra Varma

Sirdeshmukh, Ravi

Kar, Sudeshna

Gautam, Poonam https://orcid.org/0000-0002-3804-6157
Funding

Funding for this research was provided by:

Science and Engineering Research Board (YSS/2015/001321)

Indian Council of Medical Research (2014-1182)
License Information

Text and Data Mining valid from 2020-12-01

Version of Record valid from 2020-12-01
More Information

Article History

Received: 28 February 2020

Accepted: 22 November 2020

First Online: 1 December 2020

Ethics approval and consent to participate

: Clinical samples from patients visiting GIPMER, Delhi, were collected for the study after approval from the Institutional Human Ethics Committee [F.1/IEC/MAMC/(52/1/2016/No. 36) and NIP-IEC/21–12/05]. All patients provided informed consent to participate in the study and written informed consent was obtained.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current